Adar1 Capital Management, LLC Bolt Biotherapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 244,966 shares of BOLT stock, worth $1.41 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
244,966
Previous 244,966
-0.0%
Holding current value
$1.41 Million
Previous $131 Million
25.25%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding BOLT
# of Institutions
29Shares Held
18.1MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA3.81MShares$22 Million0.1% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.52MShares$20.3 Million0.38% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$15.9 Million0.08% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA1.89MShares$10.9 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.17MShares$6.74 Million0.0% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $217M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...